Skip to content

CellScape — Bruker Spatial Biology

Bruker's next-generation spatial proteomics platform; AGBT roadmap-stage announcement with specific throughput numbers not yet in public coverage.

At a glance

  • Vendor / launch date / availability: Bruker Spatial Biology; roadmap announcement at AGBT 2026 (Marco Island, Feb 22–25) per GEN AGBT 2026 recap, Feb 2026.
  • Chemistry / modality: Spatial proteomics (next-generation; specific chemistry not disclosed in AGBT public coverage).
  • Throughput (PR): Vendor PR framed CellScape as a "next-gen leap" — specific throughput numbers TBD (not surfaced in public AGBT coverage) (vendor PR — no independent benchmark).
  • Plex / antibody panel size: TBD — not surfaced in public AGBT coverage.
  • List price / reagent cost: TBD — not disclosed at AGBT.

What's new vs prior generation

CellScape is positioned by Bruker Spatial Biology as a next-generation step in their proteomics line. Specific differentiation vs prior-generation Bruker / NanoString proteomics offerings (e.g. CosMx protein channels) is not detailed in public AGBT coverage; flagged here as sparse, awaiting Bruker's full product page and post-AGBT recap content.

Headline benchmarks

"Next-gen leap" — vendor PR framing only (vendor PR — no independent benchmark) — GEN AGBT 2026 recap, Feb 2026.

All quantitative specs (plex, resolution, throughput, cost) — TBD pending vendor product page and independent benchmarks.

Reception / competitive context

GenomeWeb's AGBT spatial roundup (Feb 2026) groups CellScape with Bruker's parallel PaintScape (3D genome viz) launch as Bruker Spatial Biology's AGBT 2026 dual-track refresh. Competitive set in spatial proteomics: Akoya PhenoCycler-Fusion (incumbent multiplexed-imaging proteomics), Lunaphore COMET, and the antibody channels of Xenium RNA+Protein / MERSCOPE proteomics roadmaps.

Sources